Top

Published in:

01-08-2020 | Meningoencephalitis | Correction

Correction to: Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement

Authors: Misako Higashida-Konishi, Keisuke Izumi, Masako Tsukamoto, Hiroaki Ohya, Nozomi Takasugi, Satoshi Hama, Yutaro Hayashi, Mari Ushikubo, Kumiko Akiya, Araki Kazuhiro, Yutaka Okano, Hisaji Oshima

Published in: Clinical Rheumatology | Issue 8/2020

Excerpt

Correction to: Clinical Rheumatology …

Kitamura E, Kondo Y, Kanazawa N, Akutsu T, Nishiyama K, Iizuka T (2019) Autoimmune encephalitis as an extra-articular manifestation of rheumatoid arthritis. Intern Med 58:1007–1009CrossRef

15.

Ichiose S, Oohashi N, Watabe R, Satou S, Hoshi K, YahikoZawa H, Watanabe M (2013) A 57-year-old female case of rheumatoid meningitis with mental symptoms for which anti-cyclic citrullinated peptides antibody in the cerebrospinal fluid was useful for diagnosis. Med J Nagano Red Cross Hosp 27:110–111. (conference proceedings)

16.

Shibahara T, Matsushita T, Matsuo R, Fukushima Y, Fukuda K, Sugimori H, Kamouchi M, Kitazono T, Ago T (2016) Anti-cyclic citrullinated peptide antibody positive meningoencephalitis in the preclinical period of rheumatoid arthritis. Case Rep Neurol 8:156–160. https://doi.org/10.1159/000447627CrossRef

17.

Lubomski M, Sy J, Buckland M, Lee AS, Richards B, Thompson E, Fulham M, Breen N, Morris K, Halmagyi GM (2019) Rheumatoid leptomeningitis presenting with an acute neuropsychiatric disorder. Pract Neurol 19:68–71. https://doi.org/10.1136/practneurol-2018-001978CrossRef

18.

Nissen MS, Nilsson AC, Forsberg J, Milthers J, Wirenfeldt M, Bonde C, Byg KE, Ellingsen T, Blaabjerg M (2019) Use of cerebrospinal fluid biomarkers in diagnosis and monitoring of rheumatoid meningitis. Front Neurol 10:666CrossRef

19.

Asano K, Kamimura N, Tsuchihashi Y, Watanabe D, Takahashi R (2019) A 71-year-old female with rheumatoid meningitis who presented with characteristic imaging findings on brain MRI and was useful for diagnosis by anti-CCP antibody in cerebrospinal fluid. Rinsho Shinkeigaku (Clinical Neurology) 59:299. (conference proceedings)

Title: Correction to: Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement
Authors: Misako Higashida-Konishi
Keisuke Izumi
Masako Tsukamoto
Hiroaki Ohya
Nozomi Takasugi
Satoshi Hama
Yutaro Hayashi
Mari Ushikubo
Kumiko Akiya
Araki Kazuhiro
Yutaka Okano
Hisaji Oshima
Publication date: 01-08-2020
Publisher: Springer International Publishing
Keywords: Meningoencephalitis
Meningitis
Rheumatoid Arthritis
Encephalitis
Published in: Clinical Rheumatology / Issue 8/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-020-05223-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Correction to: Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2020

Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis

Macrophage activation syndrome associated with adult-onset Still’s disease: a multicenter retrospective analysis

Fatigue and contributing factors in Chinese patients with ankylosing spondylitis

The occurrence of sacroiliitis in HLA-B*35-positive patients with undifferentiated spondyloarthritis. A cross sectional MRI study

COVID-19 and Kawasaki disease: an analysis using Google Trends

Comment on “Colchicine may not be effective in COVID-19 infection; it may even be harmful?”

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page